Skip to main content
. 2019 Sep 23;12:1756284819877635. doi: 10.1177/1756284819877635

Figure 4.

Figure 4.

Decision tree showing different treatment options recommended by different centers for the same patients (ECOG 0–1).

ECOG, Eastern Co-operative Oncology Group Performance status; Gem, Gemcitabine; metPancr, metastatic pancreatic cancer; mFOLFIRINOX, modified regimen of oxaliplatin, leucovorin, irinotecan, and fluorouracil (5-FU); NabPac, nanoparticle albumin bound paclitaxel.

Individual experts are represented with letters “A” to “H”.